Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|May 17, 2005
[Hope and limits in cell therapies]A Bennaceur-Griscelli, W Vainchenker
Blood|January 12, 2001
Stromal cells retard the differentiation of CD34(+)CD38(low/neg) human primitive progenitors exposed to cytokines independent of their mitotic historyA Bennaceur-Griscelli, C Pondarré, V Schiavon, et al.
Blood|July 9, 1999
Murine stromal cells counteract the loss of long-term culture-initiating cell potential induced by cytokines in CD34(+)CD38(low/neg) human bone marrow cellsA Bennaceur-Griscelli, C Tourino, B Izac, et al.
British Journal of Haematology|April 7, 1999
Identification of human T-lymphoid progenitor cells in CD34+ CD38low and CD34+ CD38+ subsets of human cord blood and bone marrow cells using NOD-SCID fetal thymus organ culturesC Robin, A Bennaceur-Griscelli, F Louache, et al.
Reproductive Biomedicine Online|December 26, 2009
Characterization of human PGD blastocysts with unbalanced chromosomal translocations and human embryonic stem cell line derivation?N Frydman, O Féraud, C Bas, et al.
European Journal of Immunology|June 30, 1998
NK cells differentiated from bone marrow, cord blood and peripheral blood stem cells exhibit similar phenotype and functionsG Carayol, C Robin, J H Bourhis, et al.
Stem Cell Research|November 24, 2016
Generation of an induced pluripotent stem cell line from a patient with chronic myeloid leukemia (CML) resistant to targeted therapiesG Telliam, O Féraud, F Griscelli, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 30, 1998
Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrestF Griscelli, H Li, A Bennaceur-Griscelli, et al.
Stem Cell Research|September 20, 2017
Generation of an induced pluripotent stem cell line from a patient with hereditary multiple endocrine neoplasia 2B (MEN2B) syndrome with "highest risk" RET mutationA Bennaceur-Griscelli, J Hadoux, O Féraud, et al.
Stem Cell Research|August 26, 2016
Generation of an induced pluripotent stem cell line from a patient with hereditary multiple endocrine neoplasia 2A (MEN2A) syndrome with RET mutationJ Hadoux, O Féraud, F Griscelli, et al.
Pageof 2